COVID infection ages blood vessels, especially in women

A COVID infection, particularly in women, may lead to blood vessels aging around five years, according to research published in the European Heart Journal.

Blood vessels gradually become stiffer with age, but the new study suggests that COVID could accelerate this process. Researchers say this is important since people with stiffer blood vessels face a higher risk of cardiovascular disease, including stroke and heart attack.

Researchers know that COVID can directly affect blood vessels. They think that this may result in what they call early vascular aging, meaning that your blood vessels are older than your chronological age and you are more susceptible to heart disease. If that is happening, we need to identify who is at risk at an early stage to prevent heart attacks and strokes.

The study included 2,390 people from 16 different countries (Austria, Australia, Brazil, Canada, Cyprus, France, Greece, Italy, Mexico, Norway, Turkey, UK and US) who were recruited between September 2020 to February 2022.

They were categorized according to whether they had never had COVID, had recent COVID but were not hospitalized, hospitalized for COVID on a general ward or hospitalized for COVID in an intensive care unit.

Researchers assessed each person's vascular age with a device that measures how quickly a wave of blood pressure travels between the carotid artery (in the neck) and femoral arteries (in the legs), a measure called carotid-femoral pulse wave velocity (PWV). The higher this measurement, the stiffer the blood vessels and the higher the vascular age of a person. Measurements were taken six months after COVID infection and again after 12 months.

Researchers also recorded demographic information such as patient's sex, age and other factors that can influence cardiovascular health.

After taking these factors into consideration, researchers found that all three groups of patients who had been infected with COVID, including those with mild COVID, had stiffer arteries, compared to those who had not been infected. The effect was greater in women than in men and in people who experienced the persistent symptoms of long COVID, such as shortness of breath and fatigue.

The average increase in PWV in women who had mild COVID was 0.55 meters per second, 0.60 in women hospitalized with COVID, and 1.09 for women treated in intensive care. Researchers say an increase of around 0.5 meters per second is "clinically relevant" and equivalent to aging around five years, with a 3% increased risk of cardiovascular disease in a 60-year-old woman.

People who had been vaccinated against COVID generally had arteries that were less stiff than people who were unvaccinated. Over the longer term, the vascular aging associated with COVID infection seemed to stabilize or improve slightly.

There are several possible explanations for the vascular effects of COVID. The COVID-19 virus acts on specific receptors in the body, called the angiotensin-converting enzyme 2 receptors, that are present on the lining of the blood vessels. The virus uses these receptors to enter and infect cells.

This may result in vascular dysfunction and accelerated vascular aging. Our body's inflammation and immune responses, which defend against infections, may also be involved.

One of the reasons for the difference between women and men could be differences in the function of the immune system. Women mount a more rapid and robust immune response, which can protect them from infection. However, this same response can also increase damage to blood vessels after the initial infection.

Vascular aging is easy to measure and can be addressed with widely available treatments, such as lifestyle changes, blood pressure-lowering and cholesterol-lowering drugs. For people with accelerated vascular aging, it is important to do whatever possible to reduce the risk of heart attacks and strokes.

The researchers are working now on this aspect.

 Rosa Maria Bruno et al, Accelerated vascular ageing after COVID-19 infection: the CARTESIAN study, European Heart Journal (2025). DOI: 10.1093/eurheartj/ehaf430